Target intelligence / Profile preview

Calcium-activated chloride channel regulator 2 (CLCA2)

Target
CLCA2
Molecular classification
Ion channel regulator (modulates chloride current, but is not itself an ion channel subunit; now recognized as a self-cleaving metalloprotease which regulates calcium-activated chloride conductance), Metalloprotease (zinc-dependent), Type I transmembrane protein
01

Overview

Calcium-activated chloride channel regulator 2 (CLCA2) is a type I transmembrane protein and member of the CLCA family, widely recognized as a regulator rather than a subunit of calcium-activated chloride channels. It possesses a self-cleaving zinc metalloprotease domain and modulates calcium-dependent chloride currents principally via interaction with signaling proteins STIM-1, ORAI-1, and indirectly TMEM16A. CLCA2 plays a critical role in epithelial cell physiology, including cell adhesion, differentiation, and apoptosis, and acts as a tumor suppressor, with markedly reduced expression in a range of adenocarcinomas and cervical carcinoma. It is induced by cellular stress and is essential for proper calcium signaling and chloride channel function in epithelia, and loss of CLCA2 is associated with increased metastatic and proliferative capacity in tumor cells.

Other names
Calcium-activated chloride channel regulator 2, 109 kDa formCalcium-activated chloride channel regulator 2, 35 kDa formCACC3hCLCA2CaCC-3CLCRG2Calcium-activated chloride channel family member 2Calcium-activated chloride channel protein 3CACCchloride channel regulatorcalcium-activated chloride channel protein 3CLCA family member 2chloride channel, calcium activated, family member 2
02

Mechanism of action

For investigational approaches: Tumor suppression via inhibition of EMT and cancer cell proliferation, through modulation of the p38/JNK/ERK pathway and calcium signaling. Modulation of intracellular calcium levels and chloride current indirectly by interaction with STIM-1 and ORAI-1 and enhancement of TMEM16A activity.

03

Biological functions

Regulation of calcium-activated chloride channels (notably TMEM16A/ANO1)Regulation of store-operated calcium entry (SOCE) through interaction with STIM-1 and ORAI-1Modulation of cell adhesion and stratification of squamous epitheliaInhibition of epithelial-mesenchymal transition (EMT)Induction by p53 in response to cellular stress (cell detachment, DNA damage)Role in epithelial differentiation and apoptosis
04

Disease associations

Tumor suppressor in several cancers, especially breast, prostate, colorectal and cervical cancersDownregulated in various carcinomas (notably breast, cervical, prostate)Involved in cystic fibrosis pathogenesisAssociated with inflammatory bowel disease, familial cardiac disease, chronic lymphocytic leukemia
05

Safety considerations

No specific safety concerns reported for direct therapeutic targeting (no drugs currently approved). Challenges: tissue-specific effects and potential unintended modulation of chloride and calcium homeostasis or differentiation in non-cancerous epithelia if targeted therapeutically
06

Interacting drugs

None currently established as clinically approved direct drugs targeting CLCA2. It is a research target; overexpression or silencing is being explored in preclinical models for possible modulation of cancer progression
07

Biomarkers

Loss or reduced expression (downregulation by promoter methylation) of CLCA2 is a biomarker for poor prognosis in breast and cervical cancerPotential diagnostic and prognostic biomarker in various epithelial cancers due to its tumor suppressor role and decreased expression in malignancy

Beyond the preview

Go deeper on Calcium-activated chloride channel regulator 2 (CLCA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium-activated chloride channel regulator 2 (CLCA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call